Authors
Zhonghao Tang, Si Shen, Chen Guo, Anjie Chen, Dongjie Yang, Yan Qin, Yuanyuan Mi
Published in
Scientific reports. Jul 17, 2026. Epub Jul 17, 2026.
Abstract
According to previous studies, the CCR2-V64I polymorphism has been associated with susceptibility to various cancers, yet this relationship remains controversial. To systematically evaluate this association, we conducted a meta-analysis to summarize and validate the available evidence. We comprehensively searched the PubMed, Embase, and Cochrane Library databases and ultimately included 20 case-control studies based on relevance and quality, comprising 4438 cases and 4874 controls. The association strength was analyzed using odds ratios and 95% confidence intervals. Overall analysis revealed a potential association between the CCR2-V64I polymorphism and cancer risk. Subgroup analyses by cancer type indicated that this polymorphism served as a risk factor for oral and bladder cancers, while exerting a protective effect against cervical cancer. Further organ-system-based stratification suggested that this polymorphism was associated with an increased risk of urinary system cancers and head and neck cancers. The results of ethnic subgroup analyses indicated that this polymorphism might be associated with a significantly elevated cancer risk in Caucasian populations. These findings demonstrated that the CCR2-V64I polymorphism may significantly influence cancer susceptibility.
PMID:
42469393
Bibliographic data and abstract were imported from PubMed on 18 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0